3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
4
Rectal Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Liver Neoplasms
2
Stomach Neoplasms
1
Pain
1
Neuralgia
1
Neoplasms
1
Intestinal Perforation
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Duodenal Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Digestive System Diseases
1
Crohn Disease
1
Constipation
1
Interventions
Irinotecan
4
Oxaliplatin
3
Capecitabine
3
Bevacizumab
3
Surveys and Questionnaires
2
Leucovorin
2
Fluorouracil
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Aspirin
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
lutetium Lu 177 dotatate
1
guadecitabine
1
encorafenib
1
copper dotatate CU-64
1
alectinib
1
Ursodeoxycholic Acid
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
KRN-330
1
Folfox protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Intestinal Diseases
×
Bupivacaine
×
Gastrointestinal
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts